Volume 100 Number 9
Published online 28 April 2009 (1369 - 1516)
---------------------------------------------------------------------
British Journal of Cancer publishes high quality original papers and reviews
that make a significant contribution to increasing understanding of the causes
of cancer and to improving the treatment and survival of patients.
Visit the journal online at http://links.ealert.nature.com/ctt?kn=64&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
to view the latest research and access selected articles FREE of charge.
---------------------------------------------------------------------
British Journal of Cancer has an impact factor 4.635*
*2007 Journal Citation Report (Thomson Reuters, 2008)
----------------------
MINIREVIEW
----------------------
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
T Mashima, H Seimiya and T Tsuruo
Abstract: http://links.ealert.nature.com/ctt?kn=44&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=45&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
----------------------
CLINICAL STUDIES
----------------------
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter[quest]
S Postel-Vinay, H-T Arkenau, D Olmos, J Ang, J Barriuso, S Ashley, U Banerji, J De-Bono, I Judson and S Kaye
Abstract: http://links.ealert.nature.com/ctt?kn=84&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=91&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor
A Z Dudek, K Lesniewski-Kmak, N J Shehadeh, O N Pandey, M Franklin, R A Kratzke, E W Greeno and P Kumar
Abstract: http://links.ealert.nature.com/ctt?kn=89&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=26&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
S J Schoenleber, D M Kurtz, J A Talwalkar, L R Roberts and G J Gores
Abstract: http://links.ealert.nature.com/ctt?kn=12&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=105&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activity
L J Coleman, M B Peter, T J Teall, R A Brannan, A M Hanby, H Honarpisheh, A M Shaaban, L Smith, V Speirs, E T Verghese, J N McElwaine and T A Hughes
Abstract: http://links.ealert.nature.com/ctt?kn=102&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=9&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix
T Kasamatsu, T Onda, M Sawada, T Kato, S Ikeda, Y Sasajima and H Tsuda
Abstract: http://links.ealert.nature.com/ctt?kn=86&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=67&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
----------------------
TRANSLATIONAL THERAPEUTICS
----------------------
Potential therapeutic targets for chordoma: PI3K//AKT//TSC1//TSC2//mTOR pathway
N Presneau, A Shalaby, B Idowu, P Gikas, S R Cannon, I Gout, T Diss, R Tirabosco and A M Flanagan
Abstract: http://links.ealert.nature.com/ctt?kn=33&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=4&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Differential activation of JNK1 isoforms by TRAIL receptors modulate apoptosis of colon cancer cell lines
D Mahalingam, M Keane, G Pirianov, H Mehmet, A Samali and E Szegezdi
Abstract: http://links.ealert.nature.com/ctt?kn=39&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=59&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Activation of ATM//Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells
R P Sahu, S Batra and S K Srivastava
Abstract: http://links.ealert.nature.com/ctt?kn=20&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=74&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
----------------------
MOLECULAR DIAGNOSTICS
----------------------
Lack of complex I is associated with oncocytic thyroid tumours
F A Zimmermann, J A Mayr, D Neureiter, R Feichtinger, B Alinger, N D Jones, W Eder, W Sperl and B Kofler
Abstract: http://links.ealert.nature.com/ctt?kn=48&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=22&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Hypermethylation-mediated reduction of WWOX expression in intraductal papillary mucinous neoplasms of the pancreas
S Nakayama, S Semba, N Maeda, M Matsushita, Y Kuroda and H Yokozaki
Abstract: http://links.ealert.nature.com/ctt?kn=75&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=87&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
R Marechal, P Demetter, N Nagy, A Berton, C Decaestecker, M Polus, J Closset, J Deviere, I Salmon and J-L Van Laethem
Abstract: http://links.ealert.nature.com/ctt?kn=25&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=77&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification
M J Smith, A C Culhane, M Donovan, J C Coffey, B D Barry, M A Kelly, D G Higgins, J H Wang, W O Kirwan, T G Cotter and H P Redmond
Abstract: http://links.ealert.nature.com/ctt?kn=35&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=41&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Purinergic regulation of vascular endothelial growth factor signaling in angiogenesis
S M Rumjahn, N Yokdang, K A Baldwin, J Thai and I L O Buxton
Abstract: http://links.ealert.nature.com/ctt?kn=73&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=2&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
P F Ambros, I M Ambros, G M Brodeur, M Haber, J Khan, A Nakagawara, G Schleiermacher, F Speleman, R Spitz, W B London, S L Cohn, A D J Pearson and J M Maris
Abstract: http://links.ealert.nature.com/ctt?kn=16&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=3&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
----------------------
EPIDEMIOLOGY
----------------------
Passive smoking and risk of oesophageal and gastric adenocarcinomas
L Duan, A H Wu, J Sullivan-Halley and L Bernstein
Abstract: http://links.ealert.nature.com/ctt?kn=93&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=19&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy[quest]
L Rosenberg, K Czene and P Hall
Abstract: http://links.ealert.nature.com/ctt?kn=31&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=96&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies
L S Velentzis, M M Cantwell, C Cardwell, M R Keshtgar, A J Leathem and J V Woodside
Abstract: http://links.ealert.nature.com/ctt?kn=32&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=8&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden
J Ji, X Shu, K Sundquist, J Sundquist and K Hemminki
Abstract: http://links.ealert.nature.com/ctt?kn=13&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=60&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
A H Poulsen, S Christensen, J K McLaughlin, R W Thomsen, H T Sorensen, J H Olsen and S Friis
Abstract: http://links.ealert.nature.com/ctt?kn=101&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=108&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband
J Gronwald, C Cybulski, W Piesiak, J Suchy, T Huzarski, T Byrski, B Gorski, T Debniak, M Szwiec, D Wokolowczyk, M Matuszewski, P Sun, J Lubinski and S A Narod
Abstract: http://links.ealert.nature.com/ctt?kn=17&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=94&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
----------------------
LETTER TO THE EDITOR
----------------------
Cost analysis for cancer subgroups
P S Hall, T A Rautenberg and C McCabe
http://links.ealert.nature.com/ctt?kn=30&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
----------------------
CORRIGENDUM
----------------------
Does type 2 diabetes influence the risk of oesophageal adenocarcinoma[quest]
R E Neale, J D Doecke, N Pandeya, S Sadeghi, A C Green, P M Webb and D C Whiteman
http://links.ealert.nature.com/ctt?kn=47&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
----------------------
BOOK REVIEW
----------------------
Antiangiogenic Cancer Therapy
P H Maxwell and M Ashcroft
http://links.ealert.nature.com/ctt?kn=11&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
---------------------------------------------------------------------
Ensure your access to British Journal of Cancer
If you are unable to access the articles in this Table of Contents e-alert,
your library may not subscribe to this journal. Our online recommendation form
is a simple way to make your librarian aware that this journal is valuable to your research.
Recommend now at http://links.ealert.nature.com/ctt?kn=43&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=18&m=32680874&r=MTc2MDAwMTgxNgS2&b=2&j=NDgxNjc3MjYS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
